Merck Collaborates with Acceleration Consortium on Open-Sourcing AI-Driven Experimentation Planner
Bayesian optimization engine that already powers dozens of use cases at Merck now open sourced to foster adoption Close partnership
Read MoreBayesian optimization engine that already powers dozens of use cases at Merck now open sourced to foster adoption Close partnership
Read MoreCombines generative AI, machine learning and computer-aided drug-design to increase the success rate of new drugs and therapies Virtually screens
Read MoreMUMBAI, India and BANGALORE, India, Oct. 26, 2023 /PRNewswire/ — Merck, a leading science and technology company, in collaboration with
Read More87% of respondents deemed mRNA a key modality for the future More than 60% vaccine makers surveyed plan revamp or
Read MoreFertility Counts seeks to highlight the socio-economic impact of low birth rates on Asia-Pacific (APAC) economies. New Fertility Policy Toolkit,
Read MoreCHICAGO, Nov. 3, 2022 /PRNewswire/ — Merck KGaA, Darmstadt, Germany, a leading science and technology company, and p-Chip Corporation, a
Read MoreDÜSSELDORF, Germany, Oct. 27, 2022 /PRNewswire/ — Gerresheimer AG, a leading provider of healthcare solutions and drug delivery systems for
Read MoreReduces process development time by an estimated 40 percent Enables biopharmaceutical companies to increase the speed to clinical manufacturing Adds
Read MoreExpansion doubles production of the most highly potent active pharmaceutical ingredients (HPAPIs) Merck now one of industry’s largest manufacturers of
Read MoreNew assay brings validated HRD technology from Myriad Genetics to the Illumina TruSight™ Oncology 500, a single, comprehensive pan-cancer test to identify
Read More